The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
TW Thank for sharing recent posts.
Very balanced and cautiously optimistic
As I sit on the hotel pool area in Tenerife 29 c
I’m not looking forward to returning today to the UK weather
I’m looking forward to the next couple of weeks with Scancell GLA LTI
Thank you Crumbs
For capturing in a very well crafted mail the essence of what is happening in the current time with the company which is juggling a huge amount of work and buffeting off the external pressures in deciding the right path to follow and achieve the best result.
I agree with all you write and especially “should have sold tons in the high twenties and waited till now to plan the re- invest “
Hindsight is wonderful
Thanks again for being the voice of reason in tough times and hope others long term investors continue to hold for that AACR presentation
Matt R raised an interesting point “How is the average investor supposed to evaluate us when they can’t understand scientific speak? As the high level debates continued”
And from wigwammer
“My guess is that cellular immune response has been selected as the primary outcome because it may be more indicative of likely overall survival (the ultimate goal), including circulating tumour and so on, than tumour size”
I agree so. Why would the RNS not clarified the selection / importance of the end point goal
It may be the RNS is the wrong document to clarify this.
There are many many unknowns which need clarification
PR update please Scancell
We need a Business Director to address the smoke and mirrors that are appearing in the press.
Moderna is developing a cancer drug Shares of Moderna rise 2.5% to $164
Scancell has Clinical trials running in hospitals up and down the country
Shares in Scancell drop 12% to £.16p
We could conclude Ichor has now sold the 3 mill shares to MM’s and the share price will slowly recover.
A Business Director may have had the knowledge and time to overt this disaster
Let’s hope our new Chairman has the matter in hand.
Moderna’s announcement to fast track their new skin cancer drug.
We should be also promoting what we are doing
Scancell are conducting clinical trials in hospitals up and down the country proving positive signs that a “Cure for Cancer”may not be to for away.
We hope the impressive early results will grant a fast track status that will allow the trial to continue quickly
Needle free injection
No side effects
Safe
Complete tumour regression
Partial tumour regression
Stabilise cancer progression
No cancer reoccurrence
Prevention of secondary cancer
Proven and enhanced treatment
Low manufacturing cost
Long shelf life
No special storage requirements
Let’s inform the world what we are doing, we need an update delivered in sound bite chunks that everyone can understand and get behind Scancell
To deliver a “Cure for Cancer”
Proactive update
"The success of a human trial demonstrating that an AvidiMab-modified DNA vaccine, delivered via a needle-free injection, can induce both T-cell and antibody responses, with no safety concerns, is a pivotal proof point for Scancell's clinical strategy,” said CEO Durrant.
The company will now seek a partner to progress the COVIDITY vaccine programme and focus its resources on its portfolio of innovative immuno-oncology drug candidates.
Sounds all very upbeat. Long may it continue good update from Proactive
Chester, Thanks for your thoughts on stating trial update dates and then failing to provide any reason for a slip to Q1 23. Maybe Redmile Know the reason but no information for us PI’s
Scancell need to understand
“Under promise and over deliver”
Until we get a CEO who understands the business aspects we will continue to shoot ourself in the foot
I am hoping that our new Chairman will address this soon.
The science will no longer see us through. We need DATA update as promised
Waiting @ Gatwick for a flight to Barbados.
Two more Tuesdays before the end of the Month
So I’m waiting for a high volume trading signal on Monday23rd January that indicate we are about to receive an RNS
7.00am Tuesday 24th January RNS arrives with “block buster” Modi trial update
Good Luck to all
Followed by the interim results which have now been set for 25th January
Sounds like the perfect plan
Two more Tuesdays before the end of the Month
So I’m waiting for a high volume trading signal on Monday23rd January that indicate we are about to receive an RNS
7.00am Tuesday 24th January RNS arrives with “block buster” Modi trial update
Followed by the interim results which have now been set for 25th January
Sounds like the perfect plan
Exciting times, I think so !
And just 13 trading days until the end of the of the month
3 more Tuesdays
1 RNS required ( at least )
Waiting for a trading signal that indicate we are about to receive an RNS on the 16,23 or 30th January 2023
I’m hoping Tuesday 23rd January 2023
Let’s have a Block Buster of an RNS
Matt, you say “This is probably the only time ever that I haven't been annoyed/frustrated at Scancell missing a deadline.” I totally agree, we seem to be floating through a very calm space awaiting news, which hopefully will change our SP beyond all recognition.
Just 17 Business day’s until the end of January
The excitement continues to build before we see the little red dot. Waiting for a trading signal that indicate we are about to receive an RNS
10 years of waiting to get to this point in time
Has Lindy really discovered the holy grail and a cure for cancer
Let’s hope 2023 will be the start of
“A Cure for Cancer for the World”
CW your message 16.01 thanks for saying what everyone is also thinking
Now is the time for the support of
Team Scancell to do their job of updating us in the correct manner and BB poster’s stay calm and respectful
RNS sooon